Sébastien Hapdey
Sébastien Hapdey
Centre Henri Becquerel, Rouen
Adresse e-mail validée de
Citée par
Citée par
Comparative assessment of methods for estimating tumor volume and standardized uptake value in 18F-FDG PET
P Tylski, S Stute, N Grotus, K Doyeux, S Hapdey, I Gardin, B Vanderlinden, ...
Journal of nuclear medicine 51 (2), 268-276, 2010
Simultaneous positron emission tomography (PET) assessment of metabolism with 18F-fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine (FLT), and hypoxia …
P Vera, P Bohn, A Edet-Sanson, A Salles, S Hapdey, I Gardin, JF Ménard, ...
Radiotherapy and Oncology 98 (1), 109-116, 2011
Management of respiratory motion in PET/computed tomography: the state of the art.
A Pépin, J Daouk, P Bailly, S Hapdey, ME Meyer
Nuclear medicine communications 35 (2), 113-22, 2014
Quantitative accuracy of dopaminergic neurotransmission imaging with 123I SPECT
M Soret, PM Koulibaly, J Darcourt, S Hapdey, I Buvat
Journal of Nuclear Medicine 44 (7), 1184-1193, 2003
Development of a generic thresholding algorithm for the delineation of 18FDG-PET-positive tissue: application to the comparison of three thresholding models
S Vauclin, K Doyeux, S Hapdey, A Edet-Sanson, P Vera, I Gardin
Physics in Medicine & Biology 54 (22), 6901, 2009
Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by 18F-misonidazole PET/CT in patients with non–small cell lung carcinoma (RTEP5 study)
P Vera, S Thureau, P Chaumet-Riffaud, R Modzelewski, P Bohn, ...
Journal of Nuclear Medicine 58 (7), 1045-1053, 2017
Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC)
A Edet-Sanson, B Dubray, K Doyeux, A Back, S Hapdey, R Modzelewski, ...
Radiotherapy and Oncology 102 (2), 251-257, 2012
Baseline total metabolic tumor volume measured with fixed or different adaptive thresholding methods equally predicts outcome in peripheral T cell lymphoma
AS Cottereau, S Hapdey, L Chartier, R Modzelewski, O Casasnovas, E Itti, ...
Journal of Nuclear Medicine 58 (2), 276-281, 2017
Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma
C Lemarignier, F Di Fiore, C Marre, S Hapdey, R Modzelewski, P Gouel, ...
European journal of nuclear medicine and molecular imaging 41, 2008-2016, 2014
Does recombinant human thyrotropin-stimulated positron emission tomography with [18F] fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid …
P Vera, C Kuhn-Lansoy, A Edet-Sanson, S Hapdey, R Modzelewski, ...
Thyroid 20 (1), 15-23, 2010
FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
S Thureau, B Dubray, R Modzelewski, P Bohn, S Hapdey, S Vincent, ...
Radiation oncology 13, 1-7, 2018
Radiotherapy boost in patients with hypoxic lesions identified by 18F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome …
P Vera, SD Mihailescu, J Lequesne, R Modzelewski, P Bohn, S Hapdey, ...
European Journal of Nuclear Medicine and Molecular Imaging 46, 1448-1456, 2019
Biases affecting the measurements of tumor-to-background activity ratio in PET
M Soret, C Riddell, S Hapdey, I Buvat
IEEE Transactions on Nuclear Science 49 (5), 2112-2118, 2002
New fetal dose estimates from 18F-FDG administered during pregnancy: standardization of dose calculations and estimations with voxel-based anthropomorphic phantoms
P Zanotti-Fregonara, M Chastan, A Edet-Sanson, O Ekmekcioglu, ...
Journal of Nuclear Medicine 57 (11), 1760-1763, 2016
Quantification in simultaneous 99mTc/123I brain SPECT using generalized spectral factor analysis: a Monte Carlo study
S Hapdey, M Soret, I Buvat
Physics in Medicine & Biology 51 (23), 6157, 2006
Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET/CT in lymphoma?
P Vera, MJ Ouvrier, S Hapdey, M Thillays, AS Pesquet, B Diologent, ...
European journal of nuclear medicine and molecular imaging 34, 1943-1952, 2007
Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer
P Vera, B Dubray, O Palie, I Buvat, S Hapdey, R Modzelewski, ...
EJNMMI research 4, 1-9, 2014
Spectral factor analysis for multi-isotope imaging in nuclear medicine
I Buvat, S Hapdey, H Benali, A Todd-Pokropek, R Di Paola
Biennial International Conference on Information Processing in Medical …, 1999
First comparison between [18F]-fmiso and [18F]-faza for preoperative pet imaging of hypoxia in lung cancer
S Thureau, N Piton, P Gouel, R Modzelewski, A Dujon, JM Baste, J Melki, ...
Cancers 13 (16), 4101, 2021
Realistic and efficient modeling of radiotracer heterogeneity in Monte Carlo simulations of PET images with tumors
S Stute, S Vauclin, H Necib, N Grotus, P Tylski, NS Rehfeld, S Hapdey, ...
IEEE Transactions on Nuclear Science 59 (1), 113-122, 2012
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20